Completed OBSERVATIONAL NCT03467074

Role of Interferon-λ and Vaccine Response

Association of Genetic Polymorphisms in the Interferon-λ Signaling Cascade and Immune Response After Vaccination

Sponsor: University Hospital, Basel, Switzerland

Conditions Allogeneic Stem Cell Transplantation Vaccine Response Impaired

Updated 9 times since 2018 Last updated: Oct 15, 2019 Started: Sep 1, 2014 Primary completion: Aug 31, 2017 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Allogeneic Stem Cell Transplantation and Vaccine Response Impaired, this trial is completed. The trial is conducted by University Hospital, Basel, Switzerland and has accumulated 9 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 4 earlier versions

Nov 2019 — Nov 2020 [monthly]

Completed
Jun 2018 — Nov 2019 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Basel, Switzerland

Data source: University Hospital, Basel, Switzerland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Basel, Switzerland